admin
	admin-batch_number
	admin-bcr
	admin-day_of_dcc_upload
	admin-disease_code
	admin-file_uuid
	admin-month_of_dcc_upload
	admin-patient_withdrawal
	admin-patient_withdrawal-withdrawn
	admin-project_code
	admin-withdrawn
	admin-year_of_dcc_upload
patient
	patient-additional_pharmaceutical_therapy
	patient-additional_radiation_therapy
	patient-additional_studies
		patient-additional_studies-additional_study
		patient-additional_studies-additional_study-disease_code
		patient-additional_studies-additional_study-project_code
		patient-additional_studies-disease_code
		patient-additional_studies-project_code
	patient-additional_study
		patient-additional_study-disease_code
		patient-additional_study-project_code
		patient-additional_surgery_locoregional_procedure
		patient-additional_surgery_metastatic_procedure
	patient-age_at_initial_pathologic_diagnosis
	patient-anatomic_neoplasm_subdivision
		patient-anatomic_neoplasm_subdivisions
		patient-anatomic_neoplasm_subdivisions-anatomic_neoplasm_subdivision
	patient-anatomic_treatment_site
	patient-ann_arbor
		patient-ann_arbor-b_symptoms
		patient-ann_arbor-extranodal_involvement
	patient-axillary_lymph_node_stage_method_type
		patient-axillary_lymph_node_stage_other_method_descriptive_text
	patient-b_symptoms
	patient-bcr_drug_barcode
	patient-bcr_drug_uuid
	patient-bcr_followup_barcode
	patient-bcr_followup_uuid
	patient-bcr_patient_barcode
	patient-bcr_patient_uuid
	patient-bcr_radiation_barcode
	patient-bcr_radiation_uuid
	patient-breast_cancer_surgery_margin_status
	patient-breast_carcinoma_estrogen_receptor_status
	patient-breast_carcinoma_immunohistochemistry_er_pos_finding_scale
	patient-breast_carcinoma_immunohistochemistry_pos_cell_score
	patient-breast_carcinoma_immunohistochemistry_progesterone_receptor_pos_finding_scale
	patient-breast_carcinoma_primary_surgical_procedure_name
	patient-breast_carcinoma_progesterone_receptor_status
	patient-breast_carcinoma_surgical_procedure_name
	patient-breast_neoplasm_other_surgical_procedure_descriptive_text
	patient-clinical_M
	patient-clinical_N
	patient-clinical_T
	patient-clinical_categories
	patient-clinical_categories-clinical_M
	patient-clinical_categories-clinical_N
	patient-clinical_categories-clinical_T
	patient-clinical_stage
	patient-clinical_trail_drug_classification
	patient-course_number
	patient-cytokeratin_immunohistochemistry_staining_method_micrometastasis_indicator
	patient-day_of_form_completion
	patient-days_to_additional_surgery_locoregional_procedure
	patient-days_to_additional_surgery_metastatic_procedure
	patient-days_to_birth
	patient-days_to_death
	patient-days_to_drug_therapy_end
	patient-days_to_drug_therapy_start
	patient-days_to_initial_pathologic_diagnosis
	patient-days_to_last_followup
	patient-days_to_last_known_alive
	patient-days_to_new_tumor_event_additional_surgery_procedure
	patient-days_to_new_tumor_event_after_initial_treatment
	patient-days_to_psa
	patient-days_to_radiation_therapy_end
	patient-days_to_radiation_therapy_start
	patient-disease_code
	patient-distant_metastasis_present_ind2
	patient-drug
	patient-drug-bcr_drug_barcode
	patient-drug-bcr_drug_uuid
	patient-drug-clinical_trail_drug_classification
	patient-drug-day_of_form_completion
	patient-drug-days_to_drug_therapy_end
	patient-drug-days_to_drug_therapy_start
	patient-drug-drug_name
	patient-drug-measure_of_response
	patient-drug-month_of_form_completion
	patient-drug-number_cycles
	patient-drug-prescribed_dose
	patient-drug-prescribed_dose_units
	patient-drug-regimen_indication
	patient-drug-regimen_indication_notes
	patient-drug-regimen_number
	patient-drug-route_of_administration
	patient-drug-route_of_administrations
	patient-drug-route_of_administrations-route_of_administration
	patient-drug-therapy_ongoing
	patient-drug-therapy_type
	patient-drug-therapy_type_notes
	patient-drug-therapy_types
	patient-drug-therapy_types-therapy_type
	patient-drug-therapy_types-therapy_type_notes
	patient-drug-total_dose
	patient-drug-total_dose_units
	patient-drug-tx_on_clinical_trial
	patient-drug-year_of_form_completion
	patient-drug_name
	patient-drugs
	patient-drugs-bcr_drug_barcode
	patient-drugs-bcr_drug_uuid
	patient-drugs-clinical_trail_drug_classification
	patient-drugs-day_of_form_completion
	patient-drugs-days_to_drug_therapy_end
	patient-drugs-days_to_drug_therapy_start
	patient-drugs-drug
	patient-drugs-drug-bcr_drug_barcode
	patient-drugs-drug-bcr_drug_uuid
	patient-drugs-drug-clinical_trail_drug_classification
	patient-drugs-drug-day_of_form_completion
	patient-drugs-drug-days_to_drug_therapy_end
	patient-drugs-drug-days_to_drug_therapy_start
	patient-drugs-drug-drug_name
	patient-drugs-drug-measure_of_response
	patient-drugs-drug-month_of_form_completion
	patient-drugs-drug-number_cycles
	patient-drugs-drug-prescribed_dose
	patient-drugs-drug-prescribed_dose_units
	patient-drugs-drug-regimen_indication
	patient-drugs-drug-regimen_indication_notes
	patient-drugs-drug-regimen_number
	patient-drugs-drug-route_of_administration
	patient-drugs-drug-route_of_administrations
	patient-drugs-drug-route_of_administrations-route_of_administration
	patient-drugs-drug-therapy_ongoing
	patient-drugs-drug-therapy_type
	patient-drugs-drug-therapy_type_notes
	patient-drugs-drug-therapy_types
	patient-drugs-drug-therapy_types-therapy_type
	patient-drugs-drug-therapy_types-therapy_type_notes
	patient-drugs-drug-total_dose
	patient-drugs-drug-total_dose_units
	patient-drugs-drug-tx_on_clinical_trial
	patient-drugs-drug-year_of_form_completion
	patient-drugs-drug_name
	patient-drugs-measure_of_response
	patient-drugs-month_of_form_completion
	patient-drugs-number_cycles
	patient-drugs-prescribed_dose
	patient-drugs-prescribed_dose_units
	patient-drugs-regimen_indication
	patient-drugs-regimen_indication_notes
	patient-drugs-regimen_number
	patient-drugs-route_of_administration
	patient-drugs-route_of_administrations
	patient-drugs-route_of_administrations-route_of_administration
	patient-drugs-therapy_ongoing
	patient-drugs-therapy_type
	patient-drugs-therapy_type_notes
	patient-drugs-therapy_types
	patient-drugs-therapy_types-therapy_type
	patient-drugs-therapy_types-therapy_type_notes
	patient-drugs-total_dose
	patient-drugs-total_dose_units
	patient-drugs-tx_on_clinical_trial
	patient-drugs-year_of_form_completion
	patient-er_detection_method_text
	patient-er_level_cell_percentage_category
	patient-ethnicity
	patient-extranodal_involvement
	patient-first_nonlymph_node_metastasis_anatomic_sites
	patient-first_nonlymph_node_metastasis_anatomic_sites-metastatic_site_at_diagnosis
	patient-first_nonlymph_node_metastasis_anatomic_sites-metastatic_site_at_diagnosis_other
	patient-fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range
	patient-follow_up
	patient-follow_up-additional_pharmaceutical_therapy
	patient-follow_up-additional_radiation_therapy
	patient-follow_up-additional_surgery_locoregional_procedure
	patient-follow_up-additional_surgery_metastatic_procedure
	patient-follow_up-bcr_followup_barcode
	patient-follow_up-bcr_followup_uuid
	patient-follow_up-breast_carcinoma_estrogen_receptor_status
	patient-follow_up-breast_carcinoma_immunohistochemistry_pos_cell_score
	patient-follow_up-breast_carcinoma_progesterone_receptor_status
	patient-follow_up-day_of_form_completion
	patient-follow_up-days_to_additional_surgery_locoregional_procedure
	patient-follow_up-days_to_additional_surgery_metastatic_procedure
	patient-follow_up-days_to_death
	patient-follow_up-days_to_last_followup
	patient-follow_up-days_to_last_known_alive
	patient-follow_up-days_to_new_tumor_event_additional_surgery_procedure
	patient-follow_up-days_to_new_tumor_event_after_initial_treatment
	patient-follow_up-er_detection_method_text
	patient-follow_up-er_level_cell_percentage_category
	patient-follow_up-fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range
	patient-follow_up-followup_case_report_form_submission_reason
	patient-follow_up-her2_and_centromere_17_positive_finding_other_measurement_scale_text
	patient-follow_up-her2_erbb_method_calculation_method_text
	patient-follow_up-her2_erbb_pos_finding_cell_percent_category
	patient-follow_up-her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-follow_up-her2_immunohistochemistry_level_result
	patient-follow_up-her2_neu_and_centromere_17_copy_number_analysis_input_total_number_count
	patient-follow_up-her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count
	patient-follow_up-her2_neu_breast_carcinoma_copy_analysis_input_total_number
	patient-follow_up-her2_neu_chromosone_17_signal_ratio_value
	patient-follow_up-her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number
	patient-follow_up-immunohistochemistry_positive_cell_score
	patient-follow_up-lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-follow_up-lab_procedure_her2_neu_in_situ_hybrid_outcome_type
	patient-follow_up-lost_follow_up
	patient-follow_up-metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result
	patient-follow_up-metastatic_breast_carcinoma_estrogen_receptor_detection_method_text
	patient-follow_up-metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category
	patient-follow_up-metastatic_breast_carcinoma_estrogen_receptor_status
	patient-follow_up-metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range
	patient-follow_up-metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text
	patient-follow_up-metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category
	patient-follow_up-metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-follow_up-metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value
	patient-follow_up-metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score
	patient-follow_up-metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type
	patient-follow_up-metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score
	patient-follow_up-metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type
	patient-follow_up-metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-follow_up-metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type
	patient-follow_up-metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text
	patient-follow_up-metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text
	patient-follow_up-metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text
	patient-follow_up-metastatic_breast_carcinoma_progesterone_receptor_detection_method_text
	patient-follow_up-metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category
	patient-follow_up-metastatic_breast_carcinoma_progesterone_receptor_status
	patient-follow_up-month_of_form_completion
	patient-follow_up-new_neoplasm_event_occurrence_anatomic_site
	patient-follow_up-new_neoplasm_event_type
	patient-follow_up-new_neoplasm_occurrence_anatomic_site_text
	patient-follow_up-new_tumor_event
	patient-follow_up-new_tumor_event-additional_pharmaceutical_therapy
	patient-follow_up-new_tumor_event-additional_radiation_therapy
	patient-follow_up-new_tumor_event-days_to_new_tumor_event_additional_surgery_procedure
	patient-follow_up-new_tumor_event-days_to_new_tumor_event_after_initial_treatment
	patient-follow_up-new_tumor_event-her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count
	patient-follow_up-new_tumor_event-her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_detection_method_text
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_status
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_detection_method_text
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category
	patient-follow_up-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_status
	patient-follow_up-new_tumor_event-new_neoplasm_event_occurrence_anatomic_site
	patient-follow_up-new_tumor_event-new_neoplasm_event_type
	patient-follow_up-new_tumor_event-new_neoplasm_occurrence_anatomic_site_text
	patient-follow_up-new_tumor_event-new_tumor_event_additional_surgery_procedure
	patient-follow_up-new_tumor_event-pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text
	patient-follow_up-new_tumor_event_additional_surgery_procedure
	patient-follow_up-new_tumor_event_after_initial_treatment
	patient-follow_up-new_tumor_events
	patient-follow_up-new_tumor_events-additional_pharmaceutical_therapy
	patient-follow_up-new_tumor_events-additional_radiation_therapy
	patient-follow_up-new_tumor_events-days_to_new_tumor_event_additional_surgery_procedure
	patient-follow_up-new_tumor_events-days_to_new_tumor_event_after_initial_treatment
	patient-follow_up-new_tumor_events-her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count
	patient-follow_up-new_tumor_events-her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_estrogen_receptor_detection_method_text
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_estrogen_receptor_status
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_progesterone_receptor_detection_method_text
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category
	patient-follow_up-new_tumor_events-metastatic_breast_carcinoma_progesterone_receptor_status
	patient-follow_up-new_tumor_events-new_neoplasm_event_occurrence_anatomic_site
	patient-follow_up-new_tumor_events-new_neoplasm_event_type
	patient-follow_up-new_tumor_events-new_neoplasm_occurrence_anatomic_site_text
	patient-follow_up-new_tumor_events-new_tumor_event
	patient-follow_up-new_tumor_events-new_tumor_event-additional_pharmaceutical_therapy
	patient-follow_up-new_tumor_events-new_tumor_event-additional_radiation_therapy
	patient-follow_up-new_tumor_events-new_tumor_event-days_to_new_tumor_event_additional_surgery_procedure
	patient-follow_up-new_tumor_events-new_tumor_event-days_to_new_tumor_event_after_initial_treatment
	patient-follow_up-new_tumor_events-new_tumor_event-her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count
	patient-follow_up-new_tumor_events-new_tumor_event-her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_detection_method_text
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_status
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_detection_method_text
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category
	patient-follow_up-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_status
	patient-follow_up-new_tumor_events-new_tumor_event-new_neoplasm_event_occurrence_anatomic_site
	patient-follow_up-new_tumor_events-new_tumor_event-new_neoplasm_event_type
	patient-follow_up-new_tumor_events-new_tumor_event-new_neoplasm_occurrence_anatomic_site_text
	patient-follow_up-new_tumor_events-new_tumor_event-new_tumor_event_additional_surgery_procedure
	patient-follow_up-new_tumor_events-new_tumor_event-pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text
	patient-follow_up-new_tumor_events-new_tumor_event_additional_surgery_procedure
	patient-follow_up-new_tumor_events-new_tumor_event_after_initial_treatment
	patient-follow_up-new_tumor_events-pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text
	patient-follow_up-person_neoplasm_cancer_status
	patient-follow_up-pgr_detection_method_text
	patient-follow_up-pos_finding_her2_erbb2_other_measurement_scale_text
	patient-follow_up-pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text
	patient-follow_up-pos_finding_progesterone_receptor_other_measurement_scale_text
	patient-follow_up-positive_finding_estrogen_receptor_other_measurement_scale_text
	patient-follow_up-postoperative_rx_tx
	patient-follow_up-progesterone_receptor_level_cell_percent_category
	patient-follow_up-radiation_therapy
	patient-follow_up-targeted_molecular_therapy
	patient-follow_up-vital_status
	patient-follow_up-year_of_form_completion
	patient-follow_ups
	patient-follow_ups-additional_pharmaceutical_therapy
	patient-follow_ups-additional_radiation_therapy
	patient-follow_ups-additional_surgery_locoregional_procedure
	patient-follow_ups-additional_surgery_metastatic_procedure
	patient-follow_ups-bcr_followup_barcode
	patient-follow_ups-bcr_followup_uuid
	patient-follow_ups-breast_carcinoma_estrogen_receptor_status
	patient-follow_ups-breast_carcinoma_immunohistochemistry_pos_cell_score
	patient-follow_ups-breast_carcinoma_progesterone_receptor_status
	patient-follow_ups-day_of_form_completion
	patient-follow_ups-days_to_additional_surgery_locoregional_procedure
	patient-follow_ups-days_to_additional_surgery_metastatic_procedure
	patient-follow_ups-days_to_death
	patient-follow_ups-days_to_last_followup
	patient-follow_ups-days_to_last_known_alive
	patient-follow_ups-days_to_new_tumor_event_additional_surgery_procedure
	patient-follow_ups-days_to_new_tumor_event_after_initial_treatment
	patient-follow_ups-er_detection_method_text
	patient-follow_ups-er_level_cell_percentage_category
	patient-follow_ups-fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range
	patient-follow_ups-follow_up
	patient-follow_ups-follow_up-additional_pharmaceutical_therapy
	patient-follow_ups-follow_up-additional_radiation_therapy
	patient-follow_ups-follow_up-additional_surgery_locoregional_procedure
	patient-follow_ups-follow_up-additional_surgery_metastatic_procedure
	patient-follow_ups-follow_up-bcr_followup_barcode
	patient-follow_ups-follow_up-bcr_followup_uuid
	patient-follow_ups-follow_up-breast_carcinoma_estrogen_receptor_status
	patient-follow_ups-follow_up-breast_carcinoma_immunohistochemistry_pos_cell_score
	patient-follow_ups-follow_up-breast_carcinoma_progesterone_receptor_status
	patient-follow_ups-follow_up-day_of_form_completion
	patient-follow_ups-follow_up-days_to_additional_surgery_locoregional_procedure
	patient-follow_ups-follow_up-days_to_additional_surgery_metastatic_procedure
	patient-follow_ups-follow_up-days_to_death
	patient-follow_ups-follow_up-days_to_last_followup
	patient-follow_ups-follow_up-days_to_last_known_alive
	patient-follow_ups-follow_up-days_to_new_tumor_event_additional_surgery_procedure
	patient-follow_ups-follow_up-days_to_new_tumor_event_after_initial_treatment
	patient-follow_ups-follow_up-er_detection_method_text
	patient-follow_ups-follow_up-er_level_cell_percentage_category
	patient-follow_ups-follow_up-fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range
	patient-follow_ups-follow_up-followup_case_report_form_submission_reason
	patient-follow_ups-follow_up-her2_and_centromere_17_positive_finding_other_measurement_scale_text
	patient-follow_ups-follow_up-her2_erbb_method_calculation_method_text
	patient-follow_ups-follow_up-her2_erbb_pos_finding_cell_percent_category
	patient-follow_ups-follow_up-her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-follow_ups-follow_up-her2_immunohistochemistry_level_result
	patient-follow_ups-follow_up-her2_neu_and_centromere_17_copy_number_analysis_input_total_number_count
	patient-follow_ups-follow_up-her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count
	patient-follow_ups-follow_up-her2_neu_breast_carcinoma_copy_analysis_input_total_number
	patient-follow_ups-follow_up-her2_neu_chromosone_17_signal_ratio_value
	patient-follow_ups-follow_up-her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number
	patient-follow_ups-follow_up-immunohistochemistry_positive_cell_score
	patient-follow_ups-follow_up-lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-follow_ups-follow_up-lab_procedure_her2_neu_in_situ_hybrid_outcome_type
	patient-follow_ups-follow_up-lost_follow_up
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_estrogen_receptor_detection_method_text
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_estrogen_receptor_status
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_progesterone_receptor_detection_method_text
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category
	patient-follow_ups-follow_up-metastatic_breast_carcinoma_progesterone_receptor_status
	patient-follow_ups-follow_up-month_of_form_completion
	patient-follow_ups-follow_up-new_neoplasm_event_occurrence_anatomic_site
	patient-follow_ups-follow_up-new_neoplasm_event_type
	patient-follow_ups-follow_up-new_neoplasm_occurrence_anatomic_site_text
	patient-follow_ups-follow_up-new_tumor_event
	patient-follow_ups-follow_up-new_tumor_event-additional_pharmaceutical_therapy
	patient-follow_ups-follow_up-new_tumor_event-additional_radiation_therapy
	patient-follow_ups-follow_up-new_tumor_event-days_to_new_tumor_event_additional_surgery_procedure
	patient-follow_ups-follow_up-new_tumor_event-days_to_new_tumor_event_after_initial_treatment
	patient-follow_ups-follow_up-new_tumor_event-her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count
	patient-follow_ups-follow_up-new_tumor_event-her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_detection_method_text
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_status
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_detection_method_text
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category
	patient-follow_ups-follow_up-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_status
	patient-follow_ups-follow_up-new_tumor_event-new_neoplasm_event_occurrence_anatomic_site
	patient-follow_ups-follow_up-new_tumor_event-new_neoplasm_event_type
	patient-follow_ups-follow_up-new_tumor_event-new_neoplasm_occurrence_anatomic_site_text
	patient-follow_ups-follow_up-new_tumor_event-new_tumor_event_additional_surgery_procedure
	patient-follow_ups-follow_up-new_tumor_event-pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text
	patient-follow_ups-follow_up-new_tumor_event_additional_surgery_procedure
	patient-follow_ups-follow_up-new_tumor_event_after_initial_treatment
	patient-follow_ups-follow_up-new_tumor_events
	patient-follow_ups-follow_up-new_tumor_events-additional_pharmaceutical_therapy
	patient-follow_ups-follow_up-new_tumor_events-additional_radiation_therapy
	patient-follow_ups-follow_up-new_tumor_events-days_to_new_tumor_event_additional_surgery_procedure
	patient-follow_ups-follow_up-new_tumor_events-days_to_new_tumor_event_after_initial_treatment
	patient-follow_ups-follow_up-new_tumor_events-her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count
	patient-follow_ups-follow_up-new_tumor_events-her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_estrogen_receptor_detection_method_text
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_estrogen_receptor_status
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_progesterone_receptor_detection_method_text
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category
	patient-follow_ups-follow_up-new_tumor_events-metastatic_breast_carcinoma_progesterone_receptor_status
	patient-follow_ups-follow_up-new_tumor_events-new_neoplasm_event_occurrence_anatomic_site
	patient-follow_ups-follow_up-new_tumor_events-new_neoplasm_event_type
	patient-follow_ups-follow_up-new_tumor_events-new_neoplasm_occurrence_anatomic_site_text
	patient-follow_ups-follow_up-new_tumor_events-new_tumor_event
	patient-follow_ups-follow_up-new_tumor_events-new_tumor_event_additional_surgery_procedure
	patient-follow_ups-follow_up-new_tumor_events-new_tumor_event_after_initial_treatment
	patient-follow_ups-follow_up-new_tumor_events-pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text
	patient-follow_ups-follow_up-person_neoplasm_cancer_status
	patient-follow_ups-follow_up-pgr_detection_method_text
	patient-follow_ups-follow_up-pos_finding_her2_erbb2_other_measurement_scale_text
	patient-follow_ups-follow_up-pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text
	patient-follow_ups-follow_up-pos_finding_progesterone_receptor_other_measurement_scale_text
	patient-follow_ups-follow_up-positive_finding_estrogen_receptor_other_measurement_scale_text
	patient-follow_ups-follow_up-postoperative_rx_tx
	patient-follow_ups-follow_up-progesterone_receptor_level_cell_percent_category
	patient-follow_ups-follow_up-radiation_therapy
	patient-follow_ups-follow_up-targeted_molecular_therapy
	patient-follow_ups-follow_up-vital_status
	patient-follow_ups-follow_up-year_of_form_completion
	patient-follow_ups-followup_case_report_form_submission_reason
	patient-follow_ups-her2_and_centromere_17_positive_finding_other_measurement_scale_text
	patient-follow_ups-her2_erbb_method_calculation_method_text
	patient-follow_ups-her2_erbb_pos_finding_cell_percent_category
	patient-follow_ups-her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-follow_ups-her2_immunohistochemistry_level_result
	patient-follow_ups-her2_neu_and_centromere_17_copy_number_analysis_input_total_number_count
	patient-follow_ups-her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count
	patient-follow_ups-her2_neu_breast_carcinoma_copy_analysis_input_total_number
	patient-follow_ups-her2_neu_chromosone_17_signal_ratio_value
	patient-follow_ups-her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number
	patient-follow_ups-immunohistochemistry_positive_cell_score
	patient-follow_ups-lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-follow_ups-lab_procedure_her2_neu_in_situ_hybrid_outcome_type
	patient-follow_ups-lost_follow_up
	patient-follow_ups-metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result
	patient-follow_ups-metastatic_breast_carcinoma_estrogen_receptor_detection_method_text
	patient-follow_ups-metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category
	patient-follow_ups-metastatic_breast_carcinoma_estrogen_receptor_status
	patient-follow_ups-metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range
	patient-follow_ups-metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text
	patient-follow_ups-metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category
	patient-follow_ups-metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-follow_ups-metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value
	patient-follow_ups-metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score
	patient-follow_ups-metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type
	patient-follow_ups-metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score
	patient-follow_ups-metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type
	patient-follow_ups-metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-follow_ups-metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type
	patient-follow_ups-metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text
	patient-follow_ups-metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text
	patient-follow_ups-metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text
	patient-follow_ups-metastatic_breast_carcinoma_progesterone_receptor_detection_method_text
	patient-follow_ups-metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category
	patient-follow_ups-metastatic_breast_carcinoma_progesterone_receptor_status
	patient-follow_ups-month_of_form_completion
	patient-follow_ups-new_neoplasm_event_occurrence_anatomic_site
	patient-follow_ups-new_neoplasm_event_type
	patient-follow_ups-new_neoplasm_occurrence_anatomic_site_text
	patient-follow_ups-new_tumor_event
	patient-follow_ups-new_tumor_event-additional_pharmaceutical_therapy
	patient-follow_ups-new_tumor_event-additional_radiation_therapy
	patient-follow_ups-new_tumor_event-days_to_new_tumor_event_additional_surgery_procedure
	patient-follow_ups-new_tumor_event-days_to_new_tumor_event_after_initial_treatment
	patient-follow_ups-new_tumor_event-her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count
	patient-follow_ups-new_tumor_event-her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_detection_method_text
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_status
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_detection_method_text
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category
	patient-follow_ups-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_status
	patient-follow_ups-new_tumor_event-new_neoplasm_event_occurrence_anatomic_site
	patient-follow_ups-new_tumor_event-new_neoplasm_event_type
	patient-follow_ups-new_tumor_event-new_neoplasm_occurrence_anatomic_site_text
	patient-follow_ups-new_tumor_event-new_tumor_event_additional_surgery_procedure
	patient-follow_ups-new_tumor_event-pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text
	patient-follow_ups-new_tumor_event_additional_surgery_procedure
	patient-follow_ups-new_tumor_event_after_initial_treatment
	patient-follow_ups-new_tumor_events
	patient-follow_ups-new_tumor_events-additional_pharmaceutical_therapy
	patient-follow_ups-new_tumor_events-additional_radiation_therapy
	patient-follow_ups-new_tumor_events-days_to_new_tumor_event_additional_surgery_procedure
	patient-follow_ups-new_tumor_events-days_to_new_tumor_event_after_initial_treatment
	patient-follow_ups-new_tumor_events-her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count
	patient-follow_ups-new_tumor_events-her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_estrogen_receptor_detection_method_text
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_estrogen_receptor_status
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_progesterone_receptor_detection_method_text
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category
	patient-follow_ups-new_tumor_events-metastatic_breast_carcinoma_progesterone_receptor_status
	patient-follow_ups-new_tumor_events-new_neoplasm_event_occurrence_anatomic_site
	patient-follow_ups-new_tumor_events-new_neoplasm_event_type
	patient-follow_ups-new_tumor_events-new_neoplasm_occurrence_anatomic_site_text
	patient-follow_ups-new_tumor_events-new_tumor_event
	patient-follow_ups-new_tumor_events-new_tumor_event-additional_pharmaceutical_therapy
	patient-follow_ups-new_tumor_events-new_tumor_event-additional_radiation_therapy
	patient-follow_ups-new_tumor_events-new_tumor_event-days_to_new_tumor_event_additional_surgery_procedure
	patient-follow_ups-new_tumor_events-new_tumor_event-days_to_new_tumor_event_after_initial_treatment
	patient-follow_ups-new_tumor_events-new_tumor_event-her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count
	patient-follow_ups-new_tumor_events-new_tumor_event-her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_detection_method_text
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_status
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_detection_method_text
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category
	patient-follow_ups-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_status
	patient-follow_ups-new_tumor_events-new_tumor_event-new_neoplasm_event_occurrence_anatomic_site
	patient-follow_ups-new_tumor_events-new_tumor_event-new_neoplasm_event_type
	patient-follow_ups-new_tumor_events-new_tumor_event-new_neoplasm_occurrence_anatomic_site_text
	patient-follow_ups-new_tumor_events-new_tumor_event-new_tumor_event_additional_surgery_procedure
	patient-follow_ups-new_tumor_events-new_tumor_event-pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text
	patient-follow_ups-new_tumor_events-new_tumor_event_additional_surgery_procedure
	patient-follow_ups-new_tumor_events-new_tumor_event_after_initial_treatment
	patient-follow_ups-new_tumor_events-pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text
	patient-follow_ups-person_neoplasm_cancer_status
	patient-follow_ups-pgr_detection_method_text
	patient-follow_ups-pos_finding_her2_erbb2_other_measurement_scale_text
	patient-follow_ups-pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text
	patient-follow_ups-pos_finding_progesterone_receptor_other_measurement_scale_text
	patient-follow_ups-positive_finding_estrogen_receptor_other_measurement_scale_text
	patient-follow_ups-postoperative_rx_tx
	patient-follow_ups-progesterone_receptor_level_cell_percent_category
	patient-follow_ups-radiation_therapy
	patient-follow_ups-targeted_molecular_therapy
	patient-follow_ups-vital_status
	patient-follow_ups-year_of_form_completion
	patient-followup_case_report_form_submission_reason
	patient-gender
	patient-gleason_grading
	patient-gleason_grading-gleason_score
	patient-gleason_grading-primary_pattern
	patient-gleason_grading-secondary_pattern
	patient-gleason_grading-tertiary_pattern
	patient-gleason_score
	patient-her2_and_centromere_17_positive_finding_other_measurement_scale_text
	patient-her2_erbb_method_calculation_method_text
	patient-her2_erbb_pos_finding_cell_percent_category
	patient-her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-her2_immunohistochemistry_level_result
	patient-her2_neu_and_centromere_17_copy_number_analysis_input_total_number_count
	patient-her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count
	patient-her2_neu_breast_carcinoma_copy_analysis_input_total_number
	patient-her2_neu_chromosone_17_signal_ratio_value
	patient-her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number
	patient-histological_type
	patient-histological_type_other
	patient-history_of_neoadjuvant_treatment
	patient-icd_10
	patient-icd_o_3_histology
	patient-icd_o_3_site
	patient-igcccg_stage
	patient-immunohistochemistry_positive_cell_score
	patient-informed_consent_verified
	patient-init_pathology_dx_method_other
	patient-initial_pathologic_diagnosis_method
	patient-lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-lab_procedure_her2_neu_in_situ_hybrid_outcome_type
	patient-lost_follow_up
	patient-lymph_node_examined_count
	patient-margin_status
	patient-masaoka_stage
	patient-measure_of_response
	patient-menopause_status
	patient-metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result
	patient-metastatic_breast_carcinoma_estrogen_receptor_detection_method_text
	patient-metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category
	patient-metastatic_breast_carcinoma_estrogen_receptor_status
	patient-metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range
	patient-metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text
	patient-metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category
	patient-metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value
	patient-metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score
	patient-metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type
	patient-metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score
	patient-metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type
	patient-metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type
	patient-metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text
	patient-metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text
	patient-metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text
	patient-metastatic_breast_carcinoma_progesterone_receptor_detection_method_text
	patient-metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category
	patient-metastatic_breast_carcinoma_progesterone_receptor_status
	patient-metastatic_site_at_diagnosis
	patient-metastatic_site_at_diagnosis_other
	patient-month_of_form_completion
	patient-new_neoplasm_event_occurrence_anatomic_site
	patient-new_neoplasm_event_type
	patient-new_neoplasm_occurrence_anatomic_site_text
	patient-new_tumor_event
	patient-new_tumor_event-additional_pharmaceutical_therapy
	patient-new_tumor_event-additional_radiation_therapy
	patient-new_tumor_event-days_to_new_tumor_event_additional_surgery_procedure
	patient-new_tumor_event-days_to_new_tumor_event_after_initial_treatment
	patient-new_tumor_event-her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count
	patient-new_tumor_event-her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number
	patient-new_tumor_event-metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result
	patient-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_detection_method_text
	patient-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category
	patient-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_status
	patient-new_tumor_event-metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range
	patient-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text
	patient-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category
	patient-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-new_tumor_event-metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value
	patient-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score
	patient-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type
	patient-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score
	patient-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type
	patient-new_tumor_event-metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-new_tumor_event-metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type
	patient-new_tumor_event-metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text
	patient-new_tumor_event-metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text
	patient-new_tumor_event-metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text
	patient-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_detection_method_text
	patient-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category
	patient-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_status
	patient-new_tumor_event-new_neoplasm_event_occurrence_anatomic_site
	patient-new_tumor_event-new_neoplasm_event_type
	patient-new_tumor_event-new_neoplasm_occurrence_anatomic_site_text
	patient-new_tumor_event-new_tumor_event_additional_surgery_procedure
	patient-new_tumor_event-pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text
	patient-new_tumor_event_additional_surgery_procedure
	patient-new_tumor_event_after_initial_treatment
	patient-new_tumor_events
	patient-new_tumor_events-additional_pharmaceutical_therapy
	patient-new_tumor_events-additional_radiation_therapy
	patient-new_tumor_events-days_to_new_tumor_event_additional_surgery_procedure
	patient-new_tumor_events-days_to_new_tumor_event_after_initial_treatment
	patient-new_tumor_events-her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count
	patient-new_tumor_events-her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number
	patient-new_tumor_events-metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result
	patient-new_tumor_events-metastatic_breast_carcinoma_estrogen_receptor_detection_method_text
	patient-new_tumor_events-metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category
	patient-new_tumor_events-metastatic_breast_carcinoma_estrogen_receptor_status
	patient-new_tumor_events-metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range
	patient-new_tumor_events-metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text
	patient-new_tumor_events-metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category
	patient-new_tumor_events-metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-new_tumor_events-metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value
	patient-new_tumor_events-metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score
	patient-new_tumor_events-metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type
	patient-new_tumor_events-metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score
	patient-new_tumor_events-metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type
	patient-new_tumor_events-metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-new_tumor_events-metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type
	patient-new_tumor_events-metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text
	patient-new_tumor_events-metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text
	patient-new_tumor_events-metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text
	patient-new_tumor_events-metastatic_breast_carcinoma_progesterone_receptor_detection_method_text
	patient-new_tumor_events-metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category
	patient-new_tumor_events-metastatic_breast_carcinoma_progesterone_receptor_status
	patient-new_tumor_events-new_neoplasm_event_occurrence_anatomic_site
	patient-new_tumor_events-new_neoplasm_event_type
	patient-new_tumor_events-new_neoplasm_occurrence_anatomic_site_text
	patient-new_tumor_events-new_tumor_event
	patient-new_tumor_events-new_tumor_event-additional_pharmaceutical_therapy
	patient-new_tumor_events-new_tumor_event-additional_radiation_therapy
	patient-new_tumor_events-new_tumor_event-days_to_new_tumor_event_additional_surgery_procedure
	patient-new_tumor_events-new_tumor_event-days_to_new_tumor_event_after_initial_treatment
	patient-new_tumor_events-new_tumor_event-her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count
	patient-new_tumor_events-new_tumor_event-her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_detection_method_text
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_estrogen_receptor_status
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_detection_method_text
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category
	patient-new_tumor_events-new_tumor_event-metastatic_breast_carcinoma_progesterone_receptor_status
	patient-new_tumor_events-new_tumor_event-new_neoplasm_event_occurrence_anatomic_site
	patient-new_tumor_events-new_tumor_event-new_neoplasm_event_type
	patient-new_tumor_events-new_tumor_event-new_neoplasm_occurrence_anatomic_site_text
	patient-new_tumor_events-new_tumor_event-new_tumor_event_additional_surgery_procedure
	patient-new_tumor_events-new_tumor_event-pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text
	patient-new_tumor_events-new_tumor_event_additional_surgery_procedure
	patient-new_tumor_events-new_tumor_event_after_initial_treatment
	patient-new_tumor_events-pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text
	patient-number_cycles
	patient-number_of_lymphnodes_positive_by_he
	patient-number_of_lymphnodes_positive_by_ihc
	patient-numfractions
	patient-other_dx
	patient-pathologic_M
	patient-pathologic_N
	patient-pathologic_T
	patient-pathologic_categories
	patient-pathologic_categories-pathologic_M
	patient-pathologic_categories-pathologic_N
	patient-pathologic_categories-pathologic_T
	patient-pathologic_stage
	patient-patient_id
	patient-person_neoplasm_cancer_status
	patient-pgr_detection_method_text
	patient-pos_finding_her2_erbb2_other_measurement_scale_text
	patient-pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text
	patient-pos_finding_progesterone_receptor_other_measurement_scale_text
	patient-positive_finding_estrogen_receptor_other_measurement_scale_text
	patient-postoperative_rx_tx
	patient-prescribed_dose
	patient-prescribed_dose_units
	patient-primary_lymph_node_presentation_assessment
	patient-primary_pattern
	patient-progesterone_receptor_level_cell_percent_category
	patient-project_code
	patient-psa
	patient-psa-days_to_psa
	patient-psa-psa_value
	patient-psa_value
	patient-race
	patient-race_list
	patient-race_list-race
	patient-radiation
	patient-radiation-anatomic_treatment_site
	patient-radiation-bcr_radiation_barcode
	patient-radiation-bcr_radiation_uuid
	patient-radiation-course_number
	patient-radiation-day_of_form_completion
	patient-radiation-days_to_radiation_therapy_end
	patient-radiation-days_to_radiation_therapy_start
	patient-radiation-measure_of_response
	patient-radiation-month_of_form_completion
	patient-radiation-numfractions
	patient-radiation-radiation_dosage
	patient-radiation-radiation_treatment_ongoing
	patient-radiation-radiation_type
	patient-radiation-radiation_type_notes
	patient-radiation-regimen_indication
	patient-radiation-regimen_indication_notes
	patient-radiation-units
	patient-radiation-year_of_form_completion
	patient-radiation_dosage
	patient-radiation_therapy
	patient-radiation_treatment_ongoing
	patient-radiation_type
	patient-radiation_type_notes
	patient-radiations
	patient-radiations-anatomic_treatment_site
	patient-radiations-bcr_radiation_barcode
	patient-radiations-bcr_radiation_uuid
	patient-radiations-course_number
	patient-radiations-day_of_form_completion
	patient-radiations-days_to_radiation_therapy_end
	patient-radiations-days_to_radiation_therapy_start
	patient-radiations-measure_of_response
	patient-radiations-month_of_form_completion
	patient-radiations-numfractions
	patient-radiations-radiation
	patient-radiations-radiation-anatomic_treatment_site
	patient-radiations-radiation-bcr_radiation_barcode
	patient-radiations-radiation-bcr_radiation_uuid
	patient-radiations-radiation-course_number
	patient-radiations-radiation-day_of_form_completion
	patient-radiations-radiation-days_to_radiation_therapy_end
	patient-radiations-radiation-days_to_radiation_therapy_start
	patient-radiations-radiation-measure_of_response
	patient-radiations-radiation-month_of_form_completion
	patient-radiations-radiation-numfractions
	patient-radiations-radiation-radiation_dosage
	patient-radiations-radiation-radiation_treatment_ongoing
	patient-radiations-radiation-radiation_type
	patient-radiations-radiation-radiation_type_notes
	patient-radiations-radiation-regimen_indication
	patient-radiations-radiation-regimen_indication_notes
	patient-radiations-radiation-units
	patient-radiations-radiation-year_of_form_completion
	patient-radiations-radiation_dosage
	patient-radiations-radiation_treatment_ongoing
	patient-radiations-radiation_type
	patient-radiations-radiation_type_notes
	patient-radiations-regimen_indication
	patient-radiations-regimen_indication_notes
	patient-radiations-units
	patient-radiations-year_of_form_completion
	patient-regimen_indication
	patient-regimen_indication_notes
	patient-regimen_number
	patient-route_of_administration
	patient-route_of_administrations
	patient-route_of_administrations-route_of_administration
	patient-secondary_pattern
	patient-serum_markers
	patient-stage_event
	patient-stage_event-ann_arbor
	patient-stage_event-ann_arbor-b_symptoms
	patient-stage_event-ann_arbor-extranodal_involvement
	patient-stage_event-b_symptoms
	patient-stage_event-clinical_M
	patient-stage_event-clinical_N
	patient-stage_event-clinical_T
	patient-stage_event-clinical_categories
	patient-stage_event-clinical_categories-clinical_M
	patient-stage_event-clinical_categories-clinical_N
	patient-stage_event-clinical_categories-clinical_T
	patient-stage_event-clinical_stage
	patient-stage_event-days_to_psa
	patient-stage_event-extranodal_involvement
	patient-stage_event-gleason_grading
	patient-stage_event-gleason_grading-gleason_score
	patient-stage_event-gleason_grading-primary_pattern
	patient-stage_event-gleason_grading-secondary_pattern
	patient-stage_event-gleason_grading-tertiary_pattern
	patient-stage_event-gleason_score
	patient-stage_event-igcccg_stage
	patient-stage_event-masaoka_stage
	patient-stage_event-pathologic_M
	patient-stage_event-pathologic_N
	patient-stage_event-pathologic_T
	patient-stage_event-pathologic_categories
	patient-stage_event-pathologic_categories-pathologic_M
	patient-stage_event-pathologic_categories-pathologic_N
	patient-stage_event-pathologic_categories-pathologic_T
	patient-stage_event-pathologic_stage
	patient-stage_event-primary_pattern
	patient-stage_event-psa
	patient-stage_event-psa-days_to_psa
	patient-stage_event-psa-psa_value
	patient-stage_event-psa_value
	patient-stage_event-secondary_pattern
	patient-stage_event-serum_markers
	patient-stage_event-system_version
	patient-stage_event-tertiary_pattern
	patient-stage_event-tnm_categories
	patient-stage_event-tnm_categories-clinical_M
	patient-stage_event-tnm_categories-clinical_N
	patient-stage_event-tnm_categories-clinical_T
	patient-stage_event-tnm_categories-clinical_categories
	patient-stage_event-tnm_categories-clinical_categories-clinical_M
	patient-stage_event-tnm_categories-clinical_categories-clinical_N
	patient-stage_event-tnm_categories-clinical_categories-clinical_T
	patient-stage_event-tnm_categories-pathologic_M
	patient-stage_event-tnm_categories-pathologic_N
	patient-stage_event-tnm_categories-pathologic_T
	patient-stage_event-tnm_categories-pathologic_categories
	patient-stage_event-tnm_categories-pathologic_categories-pathologic_M
	patient-stage_event-tnm_categories-pathologic_categories-pathologic_N
	patient-stage_event-tnm_categories-pathologic_categories-pathologic_T
	patient-surgical_procedure_purpose_other_text
	patient-system_version
	patient-targeted_molecular_therapy
	patient-tertiary_pattern
	patient-therapy_ongoing
	patient-therapy_type
	patient-therapy_type_notes
	patient-therapy_types
	patient-therapy_types-therapy_type
	patient-therapy_types-therapy_type_notes
	patient-tissue_prospective_collection_indicator
	patient-tissue_retrospective_collection_indicator
	patient-tissue_source_site
	patient-tnm_categories
	patient-tnm_categories-clinical_M
	patient-tnm_categories-clinical_N
	patient-tnm_categories-clinical_T
	patient-tnm_categories-clinical_categories
	patient-tnm_categories-clinical_categories-clinical_M
	patient-tnm_categories-clinical_categories-clinical_N
	patient-tnm_categories-clinical_categories-clinical_T
	patient-tnm_categories-pathologic_M
	patient-tnm_categories-pathologic_N
	patient-tnm_categories-pathologic_T
	patient-tnm_categories-pathologic_categories
	patient-tnm_categories-pathologic_categories-pathologic_M
	patient-tnm_categories-pathologic_categories-pathologic_N
	patient-tnm_categories-pathologic_categories-pathologic_T
	patient-total_dose
	patient-total_dose_units
	patient-tumor_tissue_site
	patient-tumor_tissue_site_other
	patient-tx_on_clinical_trial
	patient-units
	patient-vital_status
	patient-year_of_form_completion
	patient-year_of_initial_pathologic_diagnosis